{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:01:57Z","timestamp":1781265717746,"version":"3.54.1"},"reference-count":146,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["joe.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,25]]},"abstract":"<jats:p>\n                    Liver fibrosis (LF) is a progressive chronic liver disease characterized by excessive accumulation of extracellular matrix, which is primarily driven by the abnormal activation of hepatic stellate cells (HSCs). Gamma-aminobutyric acid (GABA) receptors have been reported to inhibit HSC activation, while solute carrier family 32 member 1 (SLC32A1), a GABA transporter protein, is speculated to be involved in LF regulation, although its specific role and underlying molecular mechanisms remain unclear. Therefore, this study aimed to investigate the role of SLC32A1 in HSC activation and LF progression, as well as to elucidate its downstream regulatory mechanisms. Our results showed that SLC32A1 levels were elevated in LF patients.\n                    <jats:italic>In vivo<\/jats:italic>\n                    experiments demonstrated that SLC32A1 knockout alleviated CCl4-induced LF in mice.\n                    <jats:italic>In vitro<\/jats:italic>\n                    studies revealed that SLC32A1 was specifically upregulated in TGF-\u03b21-stimulated LX-2 cells (HSCs), but not in THLE-2, THP-1, or LSECs. SLC32A1 overexpression exacerbated LX-2 activation and fibrosis, while its knockdown reversed TGF-\u03b21-induced effects. Mechanistically, SLC32A1 promoted GABA and glycine exocytosis in LX-2 cells. However, neither exogenous nor endogenous GABA\/glycine affected the reduced activation mediated by SLC32A1 knockdown, prompting investigation into alternative pathways. Among 55 differentially expressed genes, PAI-1 showed the largest difference. Critically, PAI-1 overexpression reversed the decrease in activation and fibrosis induced by SLC32A1 knockdown. Collectively, these findings demonstrate that downregulation of the SLC32A1-mediated PAI-1 pathway, rather than the GABA pathway, attenuates HSC activation and LF, highlighting SLC32A1 as a potential novel therapeutic target for LF.\n                  <\/jats:p>","DOI":"10.1530\/joe-25-0300","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:12:37Z","timestamp":1779793957000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-5","source":"Crossref","is-referenced-by-count":0,"title":["Downregulation of SLC32A1 mediates the PAI-1 pathway in alleviating hepatic stellate cell activation and liver fibrosis"],"prefix":"10.1530","volume":"269","author":[{"given":"Zicheng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliate Hospital of Hunan Normal University), Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1250-1999","authenticated-orcid":true,"given":"Zhenyu","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliate Hospital of Hunan Normal University), Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliate Hospital of Hunan Normal University), Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xitao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliate Hospital of Hunan Normal University), Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5996-927X","authenticated-orcid":true,"given":"Yunfeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Hunan Provincial People\u2019s Hospital (The First Affiliate Hospital of Hunan Normal University), Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Mol Aspects Med","first-page":"37","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola M","year":"2019","unstructured":"Parola M\n & \nPinzani M\n\n. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 2019 65 37\u201355. (https:\/\/doi.org\/10.1016\/j.mam.2018.09.002)"},{"key":"bib2","series-title":"Cells","first-page":"875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen N","year":"2020","unstructured":"Roehlen N\n, \nCrouchet E\n & \nBaumert TF\n\n. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells 2020 9 875. (https:\/\/doi.org\/10.3390\/cells9040875)"},{"key":"bib3","series-title":"World J Gastroenterol","first-page":"2798","article-title":"Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF \u03b21\/Smad3 and NF-\u03baB signaling pathways","volume":"29","author":"Shi L","year":"2023","unstructured":"Shi L\n, \nZhou L\n, \nHan M\n, et al.\n Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF \u03b21\/Smad3 and NF-\u03baB signaling pathways. World J Gastroenterol 2023 29 2798\u20132817. (https:\/\/doi.org\/10.3748\/wjg.v29.i18.2798)"},{"key":"bib4","series-title":"Phytomedicine","article-title":"Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3\/HMGB1\/TLR4 signaling pathway","volume":"128","author":"Yao Y","year":"2024","unstructured":"Yao Y\n, \nZuo X\n, \nShao F\n, et al.\n Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3\/HMGB1\/TLR4 signaling pathway. Phytomedicine 2024 128 155502. (https:\/\/doi.org\/10.1016\/j.phymed.2024.155502)"},{"key":"bib5","series-title":"Drugs","first-page":"903","article-title":"Fibrosis in chronic liver disease: an update on diagnostic and treatment modalities","volume":"79","author":"Manka P","year":"2019","unstructured":"Manka P\n, \nZeller A\n & \nSyn WK\n\n. Fibrosis in chronic liver disease: an update on diagnostic and treatment modalities. Drugs 2019 79 903\u2013927. (https:\/\/doi.org\/10.1007\/s40265-019-01126-9)"},{"key":"bib6","series-title":"Hepatol Int","first-page":"614","article-title":"miR-98-5p as a novel biomarker suppress liver fibrosis by targeting TGF\u03b2 receptor 1","volume":"16","author":"Ma Y","year":"2022","unstructured":"Ma Y\n, \nYuan X\n, \nHan M\n, et al.\n miR-98-5p as a novel biomarker suppress liver fibrosis by targeting TGF\u03b2 receptor 1. Hepatol Int 2022 16 614\u2013626. (https:\/\/doi.org\/10.1007\/s12072-021-10277-5)"},{"key":"bib7","series-title":"Pharmacol Res","article-title":"Fibroblast growth factor 18 attenuates liver fibrosis and HSCs activation via the SMO-LATS1-YAP pathway","volume":"178","author":"Tong G","year":"2022","unstructured":"Tong G\n, \nChen X\n, \nLee J\n, et al.\n Fibroblast growth factor 18 attenuates liver fibrosis and HSCs activation via the SMO-LATS1-YAP pathway. Pharmacol Res 2022 178 106139. (https:\/\/doi.org\/10.1016\/j.phrs.2022.106139)"},{"key":"bib8","series-title":"Nat Rev Gastroenterol Hepatol","first-page":"633","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich L","year":"2023","unstructured":"Hammerich L\n & \nTacke F\n\n. Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol 2023 20 633\u2013646. (https:\/\/doi.org\/10.1038\/s41575-023-00807-x)"},{"key":"bib9","series-title":"Cell Death Dis","first-page":"411","article-title":"MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization","volume":"13","author":"Zhang J","year":"2022","unstructured":"Zhang J\n, \nLiu Y\n, \nChen H\n, et al.\n MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization. Cell Death Dis 2022 13 411. (https:\/\/doi.org\/10.1038\/s41419-022-04802-z)"},{"key":"bib10","series-title":"J Physiol","first-page":"1825","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm DR","year":"2022","unstructured":"Kamm DR\n & \nMcCommis KS\n\n. Hepatic stellate cells in physiology and pathology. J Physiol 2022 600 1825\u20131837. (https:\/\/doi.org\/10.1113\/jp281061)"},{"key":"bib11","series-title":"Exp Biol Med","first-page":"96","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar D","year":"2020","unstructured":"Dhar D\n, \nBaglieri J\n, \nKisseleva T\n, et al.\n Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med 2020 245 96\u2013108. (https:\/\/doi.org\/10.1177\/1535370219898141)"},{"key":"bib12","series-title":"Dig Dis Sci","first-page":"261","article-title":"The GABAB receptor inhibits activation of hepatic stellate cells","volume":"55","author":"Xiao F","year":"2010","unstructured":"Xiao F\n, \nYu K\n, \nDong F\n, et al.\n The GABAB receptor inhibits activation of hepatic stellate cells. Dig Dis Sci 2010 55 261\u2013267. (https:\/\/doi.org\/10.1007\/s10620-009-0743-2)"},{"key":"bib13","series-title":"Sci Rep","article-title":"Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis","volume":"11","author":"Bhattacharya D","year":"2021","unstructured":"Bhattacharya D\n, \nBecker C\n, \nReadhead B\n, et al.\n Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis. Sci Rep 2021 11 20827. (https:\/\/doi.org\/10.1038\/s41598-021-99008-2)"},{"key":"bib14","series-title":"Front Neural Circuits","article-title":"Developmental regulation of GABAergic gene expression in forebrain cholinergic neurons","volume":"17","author":"Granger AJ","year":"2023","unstructured":"Granger AJ\n, \nMao K\n, \nSaulnier JL\n, et al.\n Developmental regulation of GABAergic gene expression in forebrain cholinergic neurons. Front Neural Circuits 2023 17 1125071. (https:\/\/doi.org\/10.3389\/fncir.2023.1125071)"},{"key":"bib15","series-title":"J Neurosci","first-page":"4075","article-title":"Structure and function of neuronal circuits linking ventrolateral preoptic nucleus and lateral hypothalamic area","volume":"43","author":"Prokofeva K","year":"2023","unstructured":"Prokofeva K\n, \nSaito YC\n, \nNiwa Y\n, et al.\n Structure and function of neuronal circuits linking ventrolateral preoptic nucleus and lateral hypothalamic area. J Neurosci 2023 43 4075\u20134092. (https:\/\/doi.org\/10.1523\/jneurosci.1913-22.2023)"},{"key":"bib16","series-title":"Cells","first-page":"2184","article-title":"Perilipin 5 ameliorates hepatic stellate cell activation via SMAD2\/3 and SNAIL signaling pathways and suppresses STAT3 activation","volume":"10","author":"Cierpka R","year":"2021","unstructured":"Cierpka R\n, \nWeiskirchen R\n & \nAsimakopoulos A\n\n. Perilipin 5 ameliorates hepatic stellate cell activation via SMAD2\/3 and SNAIL signaling pathways and suppresses STAT3 activation. Cells 2021 10 2184. (https:\/\/doi.org\/10.3390\/cells10092184)"},{"key":"bib17","series-title":"Clin Gastroenterol Hepatol","first-page":"1893","article-title":"Hydronidone for the treatment of liver fibrosis related to chronic hepatitis B: a phase 2 randomized controlled trial","volume":"21","author":"Cai X","year":"2023","unstructured":"Cai X\n, \nLiu X\n, \nXie W\n, et al.\n Hydronidone for the treatment of liver fibrosis related to chronic hepatitis B: a phase 2 randomized controlled trial. Clin Gastroenterol Hepatol 2023 21 1893\u20131901.e7. (https:\/\/doi.org\/10.1016\/j.cgh.2022.05.056)"},{"key":"bib18","series-title":"Stem Cell Res Ther","first-page":"224","article-title":"Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt\/\u03b2-catenin signaling pathway in mice","volume":"13","author":"Liu QW","year":"2022","unstructured":"Liu QW\n, \nYing YM\n, \nZhou JX\n, et al.\n Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt\/\u03b2-catenin signaling pathway in mice. Stem Cell Res Ther 2022 13 224. (https:\/\/doi.org\/10.1186\/s13287-022-02906-z)"},{"key":"bib19","series-title":"Life Sci","article-title":"Effects of losartan and l-serine in a mouse liver fibrosis model","volume":"278","author":"Yun HH","year":"2021","unstructured":"Yun HH\n, \nPark S\n, \nChung MJ\n, et al.\n Effects of losartan and l-serine in a mouse liver fibrosis model. Life Sci 2021 278 119578. (https:\/\/doi.org\/10.1016\/j.lfs.2021.119578)"},{"key":"bib20","series-title":"Stem Cell Res Ther","first-page":"425","article-title":"Hepatic stellate cells contribute to liver regeneration through galectins in hepatic stem cell niche","volume":"11","author":"Ge JY","year":"2020","unstructured":"Ge JY\n, \nZheng YW\n, \nTsuchida T\n, et al.\n Hepatic stellate cells contribute to liver regeneration through galectins in hepatic stem cell niche. Stem Cell Res Ther 2020 11 425. (https:\/\/doi.org\/10.1186\/s13287-020-01942-x)"},{"key":"bib21","series-title":"Hepatol Commun","first-page":"855","article-title":"Presence of liver inflammation in Asian patients with chronic hepatitis B with normal ALT and detectable HBV DNA in absence of liver fibrosis","volume":"6","author":"Liu J","year":"2022","unstructured":"Liu J\n, \nWang J\n, \nYan X\n, et al.\n Presence of liver inflammation in Asian patients with chronic hepatitis B with normal ALT and detectable HBV DNA in absence of liver fibrosis. Hepatol Commun 2022 6 855\u2013866. (https:\/\/doi.org\/10.1002\/hep4.1859)"},{"key":"bib22","series-title":"Adv Sci","article-title":"Loss of SLC27A5 activates hepatic stellate cells and promotes liver fibrosis via unconjugated cholic acid","volume":"11","author":"Wu K","year":"2024","unstructured":"Wu K\n, \nLiu Y\n, \nXia J\n, et al.\n Loss of SLC27A5 activates hepatic stellate cells and promotes liver fibrosis via unconjugated cholic acid. Adv Sci 2024 11 e2304408. (https:\/\/doi.org\/10.1002\/advs.202304408)"},{"key":"bib23","series-title":"Free Radic Biol Med","first-page":"571","article-title":"Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE(2) degradation","volume":"162","author":"Zong Z","year":"2021","unstructured":"Zong Z\n, \nLiu J\n, \nWang N\n, et al.\n Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE(2) degradation. Free Radic Biol Med 2021 162 571\u2013581. (https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.11.014)"},{"key":"bib24","series-title":"J Physiol","first-page":"717","article-title":"Glutamate modulation of GABA transport in retinal horizontal cells of the skate","volume":"546","author":"Kreitzer MA","year":"2003","unstructured":"Kreitzer MA\n, \nAndersen KA\n & \nMalchow RP\n\n. Glutamate modulation of GABA transport in retinal horizontal cells of the skate. J Physiol 2003 546 717\u2013731. (https:\/\/doi.org\/10.1113\/jphysiol.2002.034421)"},{"key":"bib25","series-title":"Cryobiology","first-page":"105","article-title":"Glycine prevention of cold ischemic injury in isolated hepatocytes","volume":"28","author":"Marsh DC","year":"1991","unstructured":"Marsh DC\n, \nHjelmhaug JA\n, \nVreugdenhil PK\n, et al.\n Glycine prevention of cold ischemic injury in isolated hepatocytes. Cryobiology 1991 28 105\u2013109. (https:\/\/doi.org\/10.1016\/0011-2240(91)90012-d)"},{"key":"bib26","series-title":"ACS Chem Neurosci","first-page":"1860","article-title":"Structural determinants of the neuronal glycine transporter 2 for the selective inhibitors ALX1393 and ORG25543","volume":"12","author":"Benito-Mu\u00f1oz C","year":"2021","unstructured":"Benito-Mu\u00f1oz C\n, \nPerona A\n, \nFelipe R\n, et al.\n Structural determinants of the neuronal glycine transporter 2 for the selective inhibitors ALX1393 and ORG25543. ACS Chem Neurosci 2021 12 1860\u20131872. (https:\/\/doi.org\/10.1021\/acschemneuro.0c00602)"},{"key":"bib27","series-title":"Mol Cells","first-page":"438","article-title":"IL-6-miR-210 suppresses regulatory T cell function and promotes atrial fibrosis by targeting Foxp3","volume":"43","author":"Chen Y","year":"2020","unstructured":"Chen Y\n, \nChang G\n, \nChen X\n, et al.\n IL-6-miR-210 suppresses regulatory T cell function and promotes atrial fibrosis by targeting Foxp3. Mol Cells 2020 43 438\u2013447. (https:\/\/doi.org\/10.14348\/molcells.2019.2275)"},{"key":"bib28","series-title":"J Neuroinflammation","first-page":"182","article-title":"Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells","volume":"19","author":"Llori\u00e1n-Salvador M","year":"2022","unstructured":"Llori\u00e1n-Salvador M\n, \nByrne EM\n, \nSzczepan M\n, et al.\n Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells. J Neuroinflammation 2022 19 182. (https:\/\/doi.org\/10.1186\/s12974-022-02546-3)"},{"key":"bib29","series-title":"Sci Rep","first-page":"4172","article-title":"Mangiferin relieves CCl4-induced liver fibrosis in mice","volume":"13","author":"Zhang L","year":"2023","unstructured":"Zhang L\n, \nLiu C\n, \nYin L\n, et al.\n Mangiferin relieves CCl4-induced liver fibrosis in mice. Sci Rep 2023 13 4172. (https:\/\/doi.org\/10.1038\/s41598-023-30582-3)"},{"key":"bib30","series-title":"Pharmacol Ther","article-title":"Human PSC-derived liver cells and their applications for disease models and drug discovery","volume":"274","author":"Koui Y","year":"2025","unstructured":"Koui Y\n, \nTanaka M\n & \nKido T\n\n. Human PSC-derived liver cells and their applications for disease models and drug discovery. Pharmacol Ther 2025 274 108907. (https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108907)"},{"key":"bib31","series-title":"Int J Biol Sci","first-page":"126","article-title":"Hepatic stellate cell-derived IL-11 exacerbates liver fibrosis via interplay between HSCs and macrophages","volume":"22","author":"Zhang Y","year":"2026","unstructured":"Zhang Y\n, \nHe F\n, \nLei M\n, et al.\n Hepatic stellate cell-derived IL-11 exacerbates liver fibrosis via interplay between HSCs and macrophages. Int J Biol Sci 2026 22 126\u2013141. (https:\/\/doi.org\/10.7150\/ijbs.119659)"},{"key":"bib32","series-title":"Nat Rev Gastroenterol Hepatol","first-page":"481","article-title":"Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease","volume":"22","author":"Schwabe RF","year":"2025","unstructured":"Schwabe RF\n & \nBrenner DA\n\n. Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease. Nat Rev Gastroenterol Hepatol 2025 22 481\u2013499. (https:\/\/doi.org\/10.1038\/s41575-025-01068-6)"},{"key":"bib33","series-title":"Exp Dermatol","first-page":"1090","article-title":"LncRNA COL1A2-AS1 promotes skin fibroblast apoptosis by repressing p-Smad3 and promoting \u03b2-catenin expression","volume":"30","author":"Li J","year":"2021","unstructured":"Li J\n, \nGao Y\n, \nLi Q\n, et al.\n LncRNA COL1A2-AS1 promotes skin fibroblast apoptosis by repressing p-Smad3 and promoting \u03b2-catenin expression. Exp Dermatol 2021 30 1090\u20131098. (https:\/\/doi.org\/10.1111\/exd.14269)"},{"key":"bib34","series-title":"Oncogene","first-page":"4832","article-title":"Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway","volume":"40","author":"Bi X","year":"2021","unstructured":"Bi X\n, \nLou P\n, \nSong Y\n, et al.\n Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway. Oncogene 2021 40 4832\u20134845. (https:\/\/doi.org\/10.1038\/s41388-021-01873-8)"},{"key":"bib35","series-title":"Proc Natl Acad Sci U S A","article-title":"Neuron-specific transcriptomic signatures indicate neuroinflammation and altered neuronal activity in ASD temporal cortex","volume":"120","author":"Zhang P","year":"2023","unstructured":"Zhang P\n, \nOmanska A\n, \nAnder BP\n, et al.\n Neuron-specific transcriptomic signatures indicate neuroinflammation and altered neuronal activity in ASD temporal cortex. Proc Natl Acad Sci U S A 2023 120 e2206758120. (https:\/\/doi.org\/10.1073\/pnas.2206758120)"},{"key":"bib36","series-title":"Cell Metab","first-page":"103","article-title":"Glycine homeostasis requires reverse SHMT flux","volume":"36","author":"McBride MJ","year":"2024","unstructured":"McBride MJ\n, \nHunter CJ\n, \nZhang Z\n, et al.\n Glycine homeostasis requires reverse SHMT flux. Cell Metab 2024 36 103\u2013115.e4. (https:\/\/doi.org\/10.1016\/j.cmet.2023.12.001)"},{"key":"bib37","series-title":"Int Immunopharmacol","article-title":"Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis","volume":"99","author":"Yang F","year":"2021","unstructured":"Yang F\n, \nLi H\n, \nLi Y\n, et al.\n Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis. Int Immunopharmacol 2021 99 108051. (https:\/\/doi.org\/10.1016\/j.intimp.2021.108051)"},{"key":"bib38","series-title":"Neurology","first-page":"e2251","article-title":"Association of SLC32A1 missense variants with genetic epilepsy with febrile seizures plus","volume":"96","author":"Heron SE","year":"2021","unstructured":"Heron SE\n, \nRegan BM\n, \nHarris RV\n, et al.\n Association of SLC32A1 missense variants with genetic epilepsy with febrile seizures plus. Neurology 2021 96 e2251\u2013e2260. (https:\/\/doi.org\/10.1212\/wnl.0000000000011855)"},{"key":"bib39","series-title":"Ann Neurol","first-page":"958","article-title":"De novo missense variants in SLC32A1 cause a developmental and epileptic encephalopathy due to impaired GABAergic neurotransmission","volume":"92","author":"Platzer K","year":"2022","unstructured":"Platzer K\n, \nSticht H\n, \nBupp C\n, et al.\n De novo missense variants in SLC32A1 cause a developmental and epileptic encephalopathy due to impaired GABAergic neurotransmission. Ann Neurol 2022 92 958\u2013973. (https:\/\/doi.org\/10.1002\/ana.26485)"},{"key":"bib40","series-title":"Front Genet","article-title":"Identifying colon cancer stage related genes and their cellular pathways","volume":"14","author":"Chen B","year":"2023","unstructured":"Chen B\n, \nChakrobortty N\n, \nSaha AK\n, et al.\n Identifying colon cancer stage related genes and their cellular pathways. Front Genet 2023 14 1120185. (https:\/\/doi.org\/10.3389\/fgene.2023.1120185)"},{"key":"bib41","series-title":"Neuron","first-page":"164","article-title":"Wakefulness is governed by GABA and histamine cotransmission","volume":"87","author":"Yu X","year":"2015","unstructured":"Yu X\n, \nYe Z\n, \nHouston CM\n, et al.\n Wakefulness is governed by GABA and histamine cotransmission. Neuron 2015 87 164\u2013178. (https:\/\/doi.org\/10.1016\/j.neuron.2015.06.003)"},{"key":"bib42","series-title":"Dig Dis Sci","first-page":"1909","article-title":"\u03b3-aminobutyric acid B receptor improves carbon tetrachloride-induced liver fibrosis in rats","volume":"58","author":"Fan W","year":"2013","unstructured":"Fan W\n, \nShi BY\n, \nWei HS\n, et al\n. \u03b3-aminobutyric acid B receptor improves carbon tetrachloride-induced liver fibrosis in rats. Dig Dis Sci 2013 58 1909\u20131915. (https:\/\/doi.org\/10.1007\/s10620-013-2623-z)"},{"key":"bib43","series-title":"EXCLI J","first-page":"567","article-title":"Fibroblast growth factor-21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells","volume":"19","author":"Opoku YK","year":"2020","unstructured":"Opoku YK\n, \nLiu Z\n, \nAfrifa J\n, et al.\n Fibroblast growth factor-21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells. EXCLI J 2020 19 567\u2013581. (https:\/\/doi.org\/10.17179\/excli2020-1287)"},{"key":"bib44","series-title":"Mol Med","first-page":"80","article-title":"Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-\u03b2\/Smad pathway","volume":"28","author":"Song X","year":"2022","unstructured":"Song X\n, \nShi J\n, \nLiu J\n, et al.\n Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-\u03b2\/Smad pathway. Mol Med 2022 28 80. (https:\/\/doi.org\/10.1186\/s10020-022-00508-2)"},{"key":"bib45","series-title":"Biomark Res","first-page":"120","article-title":"Heat shock proteins (HSPs) in non-alcoholic fatty liver disease (NAFLD): from molecular mechanisms to therapeutic avenues","volume":"12","author":"Nie Z","year":"2024","unstructured":"Nie Z\n, \nXiao C\n, \nWang Y\n, et al.\n Heat shock proteins (HSPs) in non-alcoholic fatty liver disease (NAFLD): from molecular mechanisms to therapeutic avenues. Biomark Res 2024 12 120. (https:\/\/doi.org\/10.1186\/s40364-024-00664-z)"},{"key":"bib46","series-title":"Aging Dis","first-page":"731","article-title":"SLC7A11 in fibrosis: molecular mechanisms and future prospects","volume":"17","author":"Chen J","year":"2025","unstructured":"Chen J\n, \nHe Y\n, \nChen R\n, et al.\n SLC7A11 in fibrosis: molecular mechanisms and future prospects. Aging Dis 2025 17 731\u2013759. (https:\/\/doi.org\/10.14336\/ad.2025.0106)"},{"key":"bib47","series-title":"Redox Biol","article-title":"SLC7A11-ROS\/\u03b1KG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression","volume":"72","author":"Lv T","year":"2024","unstructured":"Lv T\n, \nFan X\n, \nHe C\n, et al.\n SLC7A11-ROS\/\u03b1KG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression. Redox Biol 2024 72 103159. (https:\/\/doi.org\/10.1016\/j.redox.2024.103159)"},{"key":"bib48","series-title":"Hepatology","first-page":"774","article-title":"Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation","volume":"81","author":"Zhang L","year":"2025","unstructured":"Zhang L\n, \nXie P\n, \nLi M\n, et al.\n Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation. Hepatology 2025 81 774\u2013790. (https:\/\/doi.org\/10.1097\/hep.0000000000001003)"},{"key":"bib49","series-title":"Adv Drug Deliv Rev","first-page":"27","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi T","year":"2017","unstructured":"Higashi T\n, \nFriedman SL\n & \nHoshida Y\n\n. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev 2017 121 27\u201342. (https:\/\/doi.org\/10.1016\/j.addr.2017.05.007)"},{"key":"bib50","series-title":"Hepatology","first-page":"1968","article-title":"Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis","volume":"77","author":"Knorr J","year":"2023","unstructured":"Knorr J\n, \nKaufmann B\n, \nInzaugarat ME\n, et al.\n Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Hepatology 2023 77 1968\u20131982. (https:\/\/doi.org\/10.1002\/hep.32776)"},{"key":"bib51","series-title":"Nat Commun","first-page":"6304","article-title":"Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis","volume":"14","author":"Tsuchiya Y","year":"2023","unstructured":"Tsuchiya Y\n, \nSeki T\n, \nKobayashi K\n, et al.\n Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis. Nat Commun 2023 14 6304. (https:\/\/doi.org\/10.1038\/s41467-023-42058-z)"},{"key":"bib52","series-title":"J Hepatol","first-page":"1144","article-title":"Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis","volume":"73","author":"Gao J","year":"2020","unstructured":"Gao J\n, \nWei B\n, \nde Assuncao TM\n, et al.\n Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. J Hepatol 2020 73 1144\u20131154. (https:\/\/doi.org\/10.1016\/j.jhep.2020.04.044)"},{"key":"bib53","series-title":"Phytomedicine","article-title":"Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice","volume":"101","author":"Huang S","year":"2022","unstructured":"Huang S\n, \nWang Y\n, \nXie S\n, et al.\n Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice. Phytomedicine 2022 101 154117. (https:\/\/doi.org\/10.1016\/j.phymed.2022.154117)"},{"key":"bib54","series-title":"Pharmacol Res","article-title":"Hepatic stellate cells role in the course of metabolic disorders development \u2013 a molecular overview","volume":"170","author":"Bourebaba N","year":"2021","unstructured":"Bourebaba N\n & \nMarycz K\n\n. Hepatic stellate cells role in the course of metabolic disorders development \u2013 a molecular overview. Pharmacol Res 2021 170 105739. (https:\/\/doi.org\/10.1016\/j.phrs.2021.105739)"},{"key":"bib55","series-title":"Biomed Pharmacother","article-title":"Current status of GABA receptor subtypes in analgesia","volume":"168","author":"Qian X","year":"2023","unstructured":"Qian X\n, \nZhao X\n, \nYu L\n, et al.\n Current status of GABA receptor subtypes in analgesia. Biomed Pharmacother 2023 168 115800. (https:\/\/doi.org\/10.1016\/j.biopha.2023.115800)"},{"key":"bib56","series-title":"Diabetes Obes Metab","first-page":"5085","article-title":"GABA ameliorates diet-induced hepatic steatosis and insulin resistance by inhibiting macrophage activation","volume":"27","author":"Cui Q","year":"2025","unstructured":"Cui Q\n, \nYang Q\n, \nWang Z\n, et al.\n GABA ameliorates diet-induced hepatic steatosis and insulin resistance by inhibiting macrophage activation. Diabetes Obes Metab 2025 27 5085\u20135098. (https:\/\/doi.org\/10.1111\/dom.16556)"},{"key":"bib57","series-title":"Anim Nutr","first-page":"280","article-title":"Gama-aminobutyric acid (GABA) alleviates hepatic inflammation via GABA receptors\/TLR4\/NF-\u03baB pathways in growing-finishing pigs generated by super-multiparous sows","volume":"9","author":"Zhang S","year":"2022","unstructured":"Zhang S\n, \nZhao J\n, \nHu J\n, et al.\n Gama-aminobutyric acid (GABA) alleviates hepatic inflammation via GABA receptors\/TLR4\/NF-\u03baB pathways in growing-finishing pigs generated by super-multiparous sows. Anim Nutr 2022 9 280\u2013290. (https:\/\/doi.org\/10.1016\/j.aninu.2022.02.001)"},{"key":"bib58","series-title":"Ecotoxicol Environ Saf","article-title":"Effects of ammonia toxicity on the histopathology, detoxification, oxidative stress, and immune response of the cuttlefish Sepia pharaonis and the mitigation of \u03b3-aminobutyric acid","volume":"232","author":"Liang Y","year":"2022","unstructured":"Liang Y\n, \nWu Y\n, \nLi J\n, et al.\n Effects of ammonia toxicity on the histopathology, detoxification, oxidative stress, and immune response of the cuttlefish Sepia pharaonis and the mitigation of \u03b3-aminobutyric acid. Ecotoxicol Environ Saf 2022 232 113256. (https:\/\/doi.org\/10.1016\/j.ecoenv.2022.113256)"},{"key":"bib59","series-title":"Cell Rep","article-title":"A critical role of hepatic GABA in the metabolic dysfunction and hyperphagia of obesity","volume":"35","author":"Geisler CE","year":"2021","unstructured":"Geisler CE\n, \nGhimire S\n, \nBruggink SM\n, et al.\n A critical role of hepatic GABA in the metabolic dysfunction and hyperphagia of obesity. Cell Rep 2021 35 109301. (https:\/\/doi.org\/10.1016\/j.celrep.2021.109301)"},{"key":"bib60","series-title":"Elife","article-title":"Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia\/reperfusion injury through inhibiting ferroptosis","volume":"12","author":"Wang F","year":"2024","unstructured":"Wang F\n, \nLiu X\n, \nHuang F\n, et al.\n Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia\/reperfusion injury through inhibiting ferroptosis. Elife 2024 12 RP89045. (https:\/\/doi.org\/10.7554\/eLife.89045)"},{"key":"bib61","series-title":"Dev Cell","first-page":"1053","article-title":"The de novo synthesis of GABA and its gene regulatory function control hepatocellular carcinoma metastasis","volume":"60","author":"Li L","year":"2025","unstructured":"Li L\n, \nKang Y\n, \nCheng R\n, et al.\n The de novo synthesis of GABA and its gene regulatory function control hepatocellular carcinoma metastasis. Dev Cell 2025 60 1053\u20131069.e6. (https:\/\/doi.org\/10.1016\/j.devcel.2024.12.007)"},{"key":"bib62","series-title":"Nat Methods","first-page":"635","article-title":"Ultra-high-throughput single-cell RNA sequencing and perturbation screening with combinatorial fluidic indexing","volume":"18","author":"Datlinger P","year":"2021","unstructured":"Datlinger P\n, \nRendeiro AF\n, \nBoenke T\n, et al.\n Ultra-high-throughput single-cell RNA sequencing and perturbation screening with combinatorial fluidic indexing. Nat Methods 2021 18 635\u2013642. (https:\/\/doi.org\/10.1038\/s41592-021-01153-z)"},{"key":"bib63","series-title":"Cells","first-page":"1070","article-title":"High-throughput transcriptomics of Celf1 conditional knockout lens identifies downstream networks linked to cataract pathology","volume":"12","author":"Siddam AD","year":"2023","unstructured":"Siddam AD\n, \nDuot M\n, \nCoomson SY\n, et al.\n High-throughput transcriptomics of Celf1 conditional knockout lens identifies downstream networks linked to cataract pathology. Cells 2023 12 1070. (https:\/\/doi.org\/10.3390\/cells12071070)"},{"key":"bib64","series-title":"Front Genet","article-title":"RNA sequencing and integrative analysis reveal pathways and hub genes associated with TGF\u03b21 stimulation on prostatic stromal cells","volume":"13","author":"Xiang P","year":"2022","unstructured":"Xiang P\n, \nDu Z\n, \nWang M\n, et al.\n RNA sequencing and integrative analysis reveal pathways and hub genes associated with TGF\u03b21 stimulation on prostatic stromal cells. Front Genet 2022 13 919103. (https:\/\/doi.org\/10.3389\/fgene.2022.919103)"},{"key":"bib65","series-title":"Sci Rep","article-title":"PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity","volume":"12","author":"Furuya H","year":"2022","unstructured":"Furuya H\n, \nSasaki Y\n, \nChen R\n, et al.\n PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity. Sci Rep 2022 12 12186. (https:\/\/doi.org\/10.1038\/s41598-022-16518-3)"},{"key":"bib66","series-title":"Int J Mol Sci","first-page":"5933","article-title":"Eupatilin ameliorates hepatic fibrosis and hepatic stellate cell activation by suppressing \u03b2-catenin\/PAI-1 pathway","volume":"24","author":"Hu J","year":"2023","unstructured":"Hu J\n, \nLiu Y\n, \nPan Z\n, et al.\n Eupatilin ameliorates hepatic fibrosis and hepatic stellate cell activation by suppressing \u03b2-catenin\/PAI-1 pathway. Int J Mol Sci 2023 24 5933. (https:\/\/doi.org\/10.3390\/ijms24065933)"},{"key":"bib67","series-title":"Semin Thromb Hemost","first-page":"305","article-title":"Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1)","volume":"49","author":"Morrow GB","year":"2023","unstructured":"Morrow GB\n & \nMutch NJ\n\n. Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1). Semin Thromb Hemost 2023 49 305\u2013313. (https:\/\/doi.org\/10.1055\/s-0042-1758791)"},{"key":"bib68","series-title":"Biochem Biophys Res Commun","first-page":"536","article-title":"Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-beta signaling pathway","volume":"393","author":"Min AK","year":"2010","unstructured":"Min AK\n, \nKim MK\n, \nSeo HY\n, et al.\n Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-beta signaling pathway. Biochem Biophys Res Commun 2010 393 536\u2013541. (https:\/\/doi.org\/10.1016\/j.bbrc.2010.02.050)"},{"key":"bib69","series-title":"Free Radic Biol Med","first-page":"620","article-title":"Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis","volume":"193","author":"Cho SS","year":"2022","unstructured":"Cho SS\n, \nYang JH\n, \nLee JH\n, et al.\n Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis. Free Radic Biol Med 2022 193 620\u2013637. (https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.11.011)"},{"key":"bib70","series-title":"Metabolism","article-title":"S100a16 deficiency prevents hepatic stellate cells activation and liver fibrosis via inhibiting CXCR4 expression","volume":"135","author":"Zhang WS","year":"2022","unstructured":"Zhang WS\n, \nZhang R\n, \nGe Y\n, et al.\n S100a16 deficiency prevents hepatic stellate cells activation and liver fibrosis via inhibiting CXCR4 expression. Metabolism 2022 135 155271. (https:\/\/doi.org\/10.1016\/j.metabol.2022.155271)"},{"key":"bib71","series-title":"Cell Rep","article-title":"PAI-1 uncouples integrin-\u03b21 from restrain by membrane-bound \u03b2-catenin to promote collagen fibril remodeling in obesity-related neoplasms","volume":"43","author":"Lin LL","year":"2024","unstructured":"Lin LL\n, \nNayak B\n, \nOsmulski PA\n, et al.\n PAI-1 uncouples integrin-\u03b21 from restrain by membrane-bound \u03b2-catenin to promote collagen fibril remodeling in obesity-related neoplasms. Cell Rep 2024 43 114527. (https:\/\/doi.org\/10.1016\/j.celrep.2024.114527)"},{"key":"bib72","series-title":"Front Immunol","article-title":"Herbal HuoXueTongFu formula with anti-inflammatory and fibrinolytic activity regulation for the prevention of postoperative peritoneal adhesions","volume":"15","author":"Yang L","year":"2024","unstructured":"Yang L\n, \nWang Y\n, \nLi Z\n, et al.\n Herbal HuoXueTongFu formula with anti-inflammatory and fibrinolytic activity regulation for the prevention of postoperative peritoneal adhesions. Front Immunol 2024 15 1510766. (https:\/\/doi.org\/10.3389\/fimmu.2024.1510766)"},{"key":"bib73","series-title":"Blood","first-page":"2464","article-title":"Targeting FXR in hepatocytes: a promising approach to enhance fibrinolysis and reduce deep vein thrombosis risk","volume":"146","author":"Li B","year":"2025","unstructured":"Li B\n, \nFan H\n, \nWu H\n, et al.\n Targeting FXR in hepatocytes: a promising approach to enhance fibrinolysis and reduce deep vein thrombosis risk. Blood 2025 146 2464\u20132478. (https:\/\/doi.org\/10.1182\/blood.2024027772)"},{"key":"bib1","series-title":"Mol Aspects Med","first-page":"37","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola M","year":"2019","unstructured":"Parola M\n & \nPinzani M\n\n. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 2019 65 37\u201355. (https:\/\/doi.org\/10.1016\/j.mam.2018.09.002)"},{"key":"bib2","series-title":"Cells","first-page":"875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen N","year":"2020","unstructured":"Roehlen N\n, \nCrouchet E\n & \nBaumert TF\n\n. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells 2020 9 875. (https:\/\/doi.org\/10.3390\/cells9040875)"},{"key":"bib3","series-title":"World J Gastroenterol","first-page":"2798","article-title":"Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF \u03b21\/Smad3 and NF-\u03baB signaling pathways","volume":"29","author":"Shi L","year":"2023","unstructured":"Shi L\n, \nZhou L\n, \nHan M\n, et al.\n Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF \u03b21\/Smad3 and NF-\u03baB signaling pathways. World J Gastroenterol 2023 29 2798\u20132817. (https:\/\/doi.org\/10.3748\/wjg.v29.i18.2798)"},{"key":"bib4","series-title":"Phytomedicine","article-title":"Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3\/HMGB1\/TLR4 signaling pathway","volume":"128","author":"Yao Y","year":"2024","unstructured":"Yao Y\n, \nZuo X\n, \nShao F\n, et al.\n Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3\/HMGB1\/TLR4 signaling pathway. Phytomedicine 2024 128 155502. (https:\/\/doi.org\/10.1016\/j.phymed.2024.155502)"},{"key":"bib5","series-title":"Drugs","first-page":"903","article-title":"Fibrosis in chronic liver disease: an update on diagnostic and treatment modalities","volume":"79","author":"Manka P","year":"2019","unstructured":"Manka P\n, \nZeller A\n & \nSyn WK\n\n. Fibrosis in chronic liver disease: an update on diagnostic and treatment modalities. Drugs 2019 79 903\u2013927. (https:\/\/doi.org\/10.1007\/s40265-019-01126-9)"},{"key":"bib6","series-title":"Hepatol Int","first-page":"614","article-title":"miR-98-5p as a novel biomarker suppress liver fibrosis by targeting TGF\u03b2 receptor 1","volume":"16","author":"Ma Y","year":"2022","unstructured":"Ma Y\n, \nYuan X\n, \nHan M\n, et al.\n miR-98-5p as a novel biomarker suppress liver fibrosis by targeting TGF\u03b2 receptor 1. Hepatol Int 2022 16 614\u2013626. (https:\/\/doi.org\/10.1007\/s12072-021-10277-5)"},{"key":"bib7","series-title":"Pharmacol Res","article-title":"Fibroblast growth factor 18 attenuates liver fibrosis and HSCs activation via the SMO-LATS1-YAP pathway","volume":"178","author":"Tong G","year":"2022","unstructured":"Tong G\n, \nChen X\n, \nLee J\n, et al.\n Fibroblast growth factor 18 attenuates liver fibrosis and HSCs activation via the SMO-LATS1-YAP pathway. Pharmacol Res 2022 178 106139. (https:\/\/doi.org\/10.1016\/j.phrs.2022.106139)"},{"key":"bib8","series-title":"Nat Rev Gastroenterol Hepatol","first-page":"633","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich L","year":"2023","unstructured":"Hammerich L\n & \nTacke F\n\n. Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol 2023 20 633\u2013646. (https:\/\/doi.org\/10.1038\/s41575-023-00807-x)"},{"key":"bib9","series-title":"Cell Death Dis","first-page":"411","article-title":"MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization","volume":"13","author":"Zhang J","year":"2022","unstructured":"Zhang J\n, \nLiu Y\n, \nChen H\n, et al.\n MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization. Cell Death Dis 2022 13 411. (https:\/\/doi.org\/10.1038\/s41419-022-04802-z)"},{"key":"bib10","series-title":"J Physiol","first-page":"1825","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm DR","year":"2022","unstructured":"Kamm DR\n & \nMcCommis KS\n\n. Hepatic stellate cells in physiology and pathology. J Physiol 2022 600 1825\u20131837. (https:\/\/doi.org\/10.1113\/jp281061)"},{"key":"bib11","series-title":"Exp Biol Med","first-page":"96","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar D","year":"2020","unstructured":"Dhar D\n, \nBaglieri J\n, \nKisseleva T\n, et al.\n Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med 2020 245 96\u2013108. (https:\/\/doi.org\/10.1177\/1535370219898141)"},{"key":"bib12","series-title":"Dig Dis Sci","first-page":"261","article-title":"The GABAB receptor inhibits activation of hepatic stellate cells","volume":"55","author":"Xiao F","year":"2010","unstructured":"Xiao F\n, \nYu K\n, \nDong F\n, et al.\n The GABAB receptor inhibits activation of hepatic stellate cells. Dig Dis Sci 2010 55 261\u2013267. (https:\/\/doi.org\/10.1007\/s10620-009-0743-2)"},{"key":"bib13","series-title":"Sci Rep","article-title":"Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis","volume":"11","author":"Bhattacharya D","year":"2021","unstructured":"Bhattacharya D\n, \nBecker C\n, \nReadhead B\n, et al.\n Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis. Sci Rep 2021 11 20827. (https:\/\/doi.org\/10.1038\/s41598-021-99008-2)"},{"key":"bib14","series-title":"Front Neural Circuits","article-title":"Developmental regulation of GABAergic gene expression in forebrain cholinergic neurons","volume":"17","author":"Granger AJ","year":"2023","unstructured":"Granger AJ\n, \nMao K\n, \nSaulnier JL\n, et al.\n Developmental regulation of GABAergic gene expression in forebrain cholinergic neurons. Front Neural Circuits 2023 17 1125071. (https:\/\/doi.org\/10.3389\/fncir.2023.1125071)"},{"key":"bib15","series-title":"J Neurosci","first-page":"4075","article-title":"Structure and function of neuronal circuits linking ventrolateral preoptic nucleus and lateral hypothalamic area","volume":"43","author":"Prokofeva K","year":"2023","unstructured":"Prokofeva K\n, \nSaito YC\n, \nNiwa Y\n, et al.\n Structure and function of neuronal circuits linking ventrolateral preoptic nucleus and lateral hypothalamic area. J Neurosci 2023 43 4075\u20134092. (https:\/\/doi.org\/10.1523\/jneurosci.1913-22.2023)"},{"key":"bib16","series-title":"Cells","first-page":"2184","article-title":"Perilipin 5 ameliorates hepatic stellate cell activation via SMAD2\/3 and SNAIL signaling pathways and suppresses STAT3 activation","volume":"10","author":"Cierpka R","year":"2021","unstructured":"Cierpka R\n, \nWeiskirchen R\n & \nAsimakopoulos A\n\n. Perilipin 5 ameliorates hepatic stellate cell activation via SMAD2\/3 and SNAIL signaling pathways and suppresses STAT3 activation. Cells 2021 10 2184. (https:\/\/doi.org\/10.3390\/cells10092184)"},{"key":"bib17","series-title":"Clin Gastroenterol Hepatol","first-page":"1893","article-title":"Hydronidone for the treatment of liver fibrosis related to chronic hepatitis B: a phase 2 randomized controlled trial","volume":"21","author":"Cai X","year":"2023","unstructured":"Cai X\n, \nLiu X\n, \nXie W\n, et al.\n Hydronidone for the treatment of liver fibrosis related to chronic hepatitis B: a phase 2 randomized controlled trial. Clin Gastroenterol Hepatol 2023 21 1893\u20131901.e7. (https:\/\/doi.org\/10.1016\/j.cgh.2022.05.056)"},{"key":"bib18","series-title":"Stem Cell Res Ther","first-page":"224","article-title":"Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt\/\u03b2-catenin signaling pathway in mice","volume":"13","author":"Liu QW","year":"2022","unstructured":"Liu QW\n, \nYing YM\n, \nZhou JX\n, et al.\n Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt\/\u03b2-catenin signaling pathway in mice. Stem Cell Res Ther 2022 13 224. (https:\/\/doi.org\/10.1186\/s13287-022-02906-z)"},{"key":"bib19","series-title":"Life Sci","article-title":"Effects of losartan and l-serine in a mouse liver fibrosis model","volume":"278","author":"Yun HH","year":"2021","unstructured":"Yun HH\n, \nPark S\n, \nChung MJ\n, et al.\n Effects of losartan and l-serine in a mouse liver fibrosis model. Life Sci 2021 278 119578. (https:\/\/doi.org\/10.1016\/j.lfs.2021.119578)"},{"key":"bib20","series-title":"Stem Cell Res Ther","first-page":"425","article-title":"Hepatic stellate cells contribute to liver regeneration through galectins in hepatic stem cell niche","volume":"11","author":"Ge JY","year":"2020","unstructured":"Ge JY\n, \nZheng YW\n, \nTsuchida T\n, et al.\n Hepatic stellate cells contribute to liver regeneration through galectins in hepatic stem cell niche. Stem Cell Res Ther 2020 11 425. (https:\/\/doi.org\/10.1186\/s13287-020-01942-x)"},{"key":"bib21","series-title":"Hepatol Commun","first-page":"855","article-title":"Presence of liver inflammation in Asian patients with chronic hepatitis B with normal ALT and detectable HBV DNA in absence of liver fibrosis","volume":"6","author":"Liu J","year":"2022","unstructured":"Liu J\n, \nWang J\n, \nYan X\n, et al.\n Presence of liver inflammation in Asian patients with chronic hepatitis B with normal ALT and detectable HBV DNA in absence of liver fibrosis. Hepatol Commun 2022 6 855\u2013866. (https:\/\/doi.org\/10.1002\/hep4.1859)"},{"key":"bib22","series-title":"Adv Sci","article-title":"Loss of SLC27A5 activates hepatic stellate cells and promotes liver fibrosis via unconjugated cholic acid","volume":"11","author":"Wu K","year":"2024","unstructured":"Wu K\n, \nLiu Y\n, \nXia J\n, et al.\n Loss of SLC27A5 activates hepatic stellate cells and promotes liver fibrosis via unconjugated cholic acid. Adv Sci 2024 11 e2304408. (https:\/\/doi.org\/10.1002\/advs.202304408)"},{"key":"bib23","series-title":"Free Radic Biol Med","first-page":"571","article-title":"Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE(2) degradation","volume":"162","author":"Zong Z","year":"2021","unstructured":"Zong Z\n, \nLiu J\n, \nWang N\n, et al.\n Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE(2) degradation. Free Radic Biol Med 2021 162 571\u2013581. (https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.11.014)"},{"key":"bib24","series-title":"J Physiol","first-page":"717","article-title":"Glutamate modulation of GABA transport in retinal horizontal cells of the skate","volume":"546","author":"Kreitzer MA","year":"2003","unstructured":"Kreitzer MA\n, \nAndersen KA\n & \nMalchow RP\n\n. Glutamate modulation of GABA transport in retinal horizontal cells of the skate. J Physiol 2003 546 717\u2013731. (https:\/\/doi.org\/10.1113\/jphysiol.2002.034421)"},{"key":"bib25","series-title":"Cryobiology","first-page":"105","article-title":"Glycine prevention of cold ischemic injury in isolated hepatocytes","volume":"28","author":"Marsh DC","year":"1991","unstructured":"Marsh DC\n, \nHjelmhaug JA\n, \nVreugdenhil PK\n, et al.\n Glycine prevention of cold ischemic injury in isolated hepatocytes. Cryobiology 1991 28 105\u2013109. (https:\/\/doi.org\/10.1016\/0011-2240(91)90012-d)"},{"key":"bib26","series-title":"ACS Chem Neurosci","first-page":"1860","article-title":"Structural determinants of the neuronal glycine transporter 2 for the selective inhibitors ALX1393 and ORG25543","volume":"12","author":"Benito-Mu\u00f1oz C","year":"2021","unstructured":"Benito-Mu\u00f1oz C\n, \nPerona A\n, \nFelipe R\n, et al.\n Structural determinants of the neuronal glycine transporter 2 for the selective inhibitors ALX1393 and ORG25543. ACS Chem Neurosci 2021 12 1860\u20131872. (https:\/\/doi.org\/10.1021\/acschemneuro.0c00602)"},{"key":"bib27","series-title":"Mol Cells","first-page":"438","article-title":"IL-6-miR-210 suppresses regulatory T cell function and promotes atrial fibrosis by targeting Foxp3","volume":"43","author":"Chen Y","year":"2020","unstructured":"Chen Y\n, \nChang G\n, \nChen X\n, et al.\n IL-6-miR-210 suppresses regulatory T cell function and promotes atrial fibrosis by targeting Foxp3. Mol Cells 2020 43 438\u2013447. (https:\/\/doi.org\/10.14348\/molcells.2019.2275)"},{"key":"bib28","series-title":"J Neuroinflammation","first-page":"182","article-title":"Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells","volume":"19","author":"Llori\u00e1n-Salvador M","year":"2022","unstructured":"Llori\u00e1n-Salvador M\n, \nByrne EM\n, \nSzczepan M\n, et al.\n Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells. J Neuroinflammation 2022 19 182. (https:\/\/doi.org\/10.1186\/s12974-022-02546-3)"},{"key":"bib29","series-title":"Sci Rep","first-page":"4172","article-title":"Mangiferin relieves CCl4-induced liver fibrosis in mice","volume":"13","author":"Zhang L","year":"2023","unstructured":"Zhang L\n, \nLiu C\n, \nYin L\n, et al.\n Mangiferin relieves CCl4-induced liver fibrosis in mice. Sci Rep 2023 13 4172. (https:\/\/doi.org\/10.1038\/s41598-023-30582-3)"},{"key":"bib30","series-title":"Pharmacol Ther","article-title":"Human PSC-derived liver cells and their applications for disease models and drug discovery","volume":"274","author":"Koui Y","year":"2025","unstructured":"Koui Y\n, \nTanaka M\n & \nKido T\n\n. Human PSC-derived liver cells and their applications for disease models and drug discovery. Pharmacol Ther 2025 274 108907. (https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108907)"},{"key":"bib31","series-title":"Int J Biol Sci","first-page":"126","article-title":"Hepatic stellate cell-derived IL-11 exacerbates liver fibrosis via interplay between HSCs and macrophages","volume":"22","author":"Zhang Y","year":"2026","unstructured":"Zhang Y\n, \nHe F\n, \nLei M\n, et al.\n Hepatic stellate cell-derived IL-11 exacerbates liver fibrosis via interplay between HSCs and macrophages. Int J Biol Sci 2026 22 126\u2013141. (https:\/\/doi.org\/10.7150\/ijbs.119659)"},{"key":"bib32","series-title":"Nat Rev Gastroenterol Hepatol","first-page":"481","article-title":"Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease","volume":"22","author":"Schwabe RF","year":"2025","unstructured":"Schwabe RF\n & \nBrenner DA\n\n. Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease. Nat Rev Gastroenterol Hepatol 2025 22 481\u2013499. (https:\/\/doi.org\/10.1038\/s41575-025-01068-6)"},{"key":"bib33","series-title":"Exp Dermatol","first-page":"1090","article-title":"LncRNA COL1A2-AS1 promotes skin fibroblast apoptosis by repressing p-Smad3 and promoting \u03b2-catenin expression","volume":"30","author":"Li J","year":"2021","unstructured":"Li J\n, \nGao Y\n, \nLi Q\n, et al.\n LncRNA COL1A2-AS1 promotes skin fibroblast apoptosis by repressing p-Smad3 and promoting \u03b2-catenin expression. Exp Dermatol 2021 30 1090\u20131098. (https:\/\/doi.org\/10.1111\/exd.14269)"},{"key":"bib34","series-title":"Oncogene","first-page":"4832","article-title":"Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway","volume":"40","author":"Bi X","year":"2021","unstructured":"Bi X\n, \nLou P\n, \nSong Y\n, et al.\n Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway. Oncogene 2021 40 4832\u20134845. (https:\/\/doi.org\/10.1038\/s41388-021-01873-8)"},{"key":"bib35","series-title":"Proc Natl Acad Sci U S A","article-title":"Neuron-specific transcriptomic signatures indicate neuroinflammation and altered neuronal activity in ASD temporal cortex","volume":"120","author":"Zhang P","year":"2023","unstructured":"Zhang P\n, \nOmanska A\n, \nAnder BP\n, et al.\n Neuron-specific transcriptomic signatures indicate neuroinflammation and altered neuronal activity in ASD temporal cortex. Proc Natl Acad Sci U S A 2023 120 e2206758120. (https:\/\/doi.org\/10.1073\/pnas.2206758120)"},{"key":"bib36","series-title":"Cell Metab","first-page":"103","article-title":"Glycine homeostasis requires reverse SHMT flux","volume":"36","author":"McBride MJ","year":"2024","unstructured":"McBride MJ\n, \nHunter CJ\n, \nZhang Z\n, et al.\n Glycine homeostasis requires reverse SHMT flux. Cell Metab 2024 36 103\u2013115.e4. (https:\/\/doi.org\/10.1016\/j.cmet.2023.12.001)"},{"key":"bib37","series-title":"Int Immunopharmacol","article-title":"Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis","volume":"99","author":"Yang F","year":"2021","unstructured":"Yang F\n, \nLi H\n, \nLi Y\n, et al.\n Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis. Int Immunopharmacol 2021 99 108051. (https:\/\/doi.org\/10.1016\/j.intimp.2021.108051)"},{"key":"bib38","series-title":"Neurology","first-page":"e2251","article-title":"Association of SLC32A1 missense variants with genetic epilepsy with febrile seizures plus","volume":"96","author":"Heron SE","year":"2021","unstructured":"Heron SE\n, \nRegan BM\n, \nHarris RV\n, et al.\n Association of SLC32A1 missense variants with genetic epilepsy with febrile seizures plus. Neurology 2021 96 e2251\u2013e2260. (https:\/\/doi.org\/10.1212\/wnl.0000000000011855)"},{"key":"bib39","series-title":"Ann Neurol","first-page":"958","article-title":"De novo missense variants in SLC32A1 cause a developmental and epileptic encephalopathy due to impaired GABAergic neurotransmission","volume":"92","author":"Platzer K","year":"2022","unstructured":"Platzer K\n, \nSticht H\n, \nBupp C\n, et al.\n De novo missense variants in SLC32A1 cause a developmental and epileptic encephalopathy due to impaired GABAergic neurotransmission. Ann Neurol 2022 92 958\u2013973. (https:\/\/doi.org\/10.1002\/ana.26485)"},{"key":"bib40","series-title":"Front Genet","article-title":"Identifying colon cancer stage related genes and their cellular pathways","volume":"14","author":"Chen B","year":"2023","unstructured":"Chen B\n, \nChakrobortty N\n, \nSaha AK\n, et al.\n Identifying colon cancer stage related genes and their cellular pathways. Front Genet 2023 14 1120185. (https:\/\/doi.org\/10.3389\/fgene.2023.1120185)"},{"key":"bib41","series-title":"Neuron","first-page":"164","article-title":"Wakefulness is governed by GABA and histamine cotransmission","volume":"87","author":"Yu X","year":"2015","unstructured":"Yu X\n, \nYe Z\n, \nHouston CM\n, et al.\n Wakefulness is governed by GABA and histamine cotransmission. Neuron 2015 87 164\u2013178. (https:\/\/doi.org\/10.1016\/j.neuron.2015.06.003)"},{"key":"bib42","series-title":"Dig Dis Sci","first-page":"1909","article-title":"\u03b3-aminobutyric acid B receptor improves carbon tetrachloride-induced liver fibrosis in rats","volume":"58","author":"Fan W","year":"2013","unstructured":"Fan W\n, \nShi BY\n, \nWei HS\n, et al\n. \u03b3-aminobutyric acid B receptor improves carbon tetrachloride-induced liver fibrosis in rats. Dig Dis Sci 2013 58 1909\u20131915. (https:\/\/doi.org\/10.1007\/s10620-013-2623-z)"},{"key":"bib43","series-title":"EXCLI J","first-page":"567","article-title":"Fibroblast growth factor-21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells","volume":"19","author":"Opoku YK","year":"2020","unstructured":"Opoku YK\n, \nLiu Z\n, \nAfrifa J\n, et al.\n Fibroblast growth factor-21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells. EXCLI J 2020 19 567\u2013581. (https:\/\/doi.org\/10.17179\/excli2020-1287)"},{"key":"bib44","series-title":"Mol Med","first-page":"80","article-title":"Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-\u03b2\/Smad pathway","volume":"28","author":"Song X","year":"2022","unstructured":"Song X\n, \nShi J\n, \nLiu J\n, et al.\n Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-\u03b2\/Smad pathway. Mol Med 2022 28 80. (https:\/\/doi.org\/10.1186\/s10020-022-00508-2)"},{"key":"bib45","series-title":"Biomark Res","first-page":"120","article-title":"Heat shock proteins (HSPs) in non-alcoholic fatty liver disease (NAFLD): from molecular mechanisms to therapeutic avenues","volume":"12","author":"Nie Z","year":"2024","unstructured":"Nie Z\n, \nXiao C\n, \nWang Y\n, et al.\n Heat shock proteins (HSPs) in non-alcoholic fatty liver disease (NAFLD): from molecular mechanisms to therapeutic avenues. Biomark Res 2024 12 120. (https:\/\/doi.org\/10.1186\/s40364-024-00664-z)"},{"key":"bib46","series-title":"Aging Dis","first-page":"731","article-title":"SLC7A11 in fibrosis: molecular mechanisms and future prospects","volume":"17","author":"Chen J","year":"2025","unstructured":"Chen J\n, \nHe Y\n, \nChen R\n, et al.\n SLC7A11 in fibrosis: molecular mechanisms and future prospects. Aging Dis 2025 17 731\u2013759. (https:\/\/doi.org\/10.14336\/ad.2025.0106)"},{"key":"bib47","series-title":"Redox Biol","article-title":"SLC7A11-ROS\/\u03b1KG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression","volume":"72","author":"Lv T","year":"2024","unstructured":"Lv T\n, \nFan X\n, \nHe C\n, et al.\n SLC7A11-ROS\/\u03b1KG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression. Redox Biol 2024 72 103159. (https:\/\/doi.org\/10.1016\/j.redox.2024.103159)"},{"key":"bib48","series-title":"Hepatology","first-page":"774","article-title":"Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation","volume":"81","author":"Zhang L","year":"2025","unstructured":"Zhang L\n, \nXie P\n, \nLi M\n, et al.\n Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation. Hepatology 2025 81 774\u2013790. (https:\/\/doi.org\/10.1097\/hep.0000000000001003)"},{"key":"bib49","series-title":"Adv Drug Deliv Rev","first-page":"27","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi T","year":"2017","unstructured":"Higashi T\n, \nFriedman SL\n & \nHoshida Y\n\n. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev 2017 121 27\u201342. (https:\/\/doi.org\/10.1016\/j.addr.2017.05.007)"},{"key":"bib50","series-title":"Hepatology","first-page":"1968","article-title":"Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis","volume":"77","author":"Knorr J","year":"2023","unstructured":"Knorr J\n, \nKaufmann B\n, \nInzaugarat ME\n, et al.\n Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Hepatology 2023 77 1968\u20131982. (https:\/\/doi.org\/10.1002\/hep.32776)"},{"key":"bib51","series-title":"Nat Commun","first-page":"6304","article-title":"Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis","volume":"14","author":"Tsuchiya Y","year":"2023","unstructured":"Tsuchiya Y\n, \nSeki T\n, \nKobayashi K\n, et al.\n Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis. Nat Commun 2023 14 6304. (https:\/\/doi.org\/10.1038\/s41467-023-42058-z)"},{"key":"bib52","series-title":"J Hepatol","first-page":"1144","article-title":"Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis","volume":"73","author":"Gao J","year":"2020","unstructured":"Gao J\n, \nWei B\n, \nde Assuncao TM\n, et al.\n Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. J Hepatol 2020 73 1144\u20131154. (https:\/\/doi.org\/10.1016\/j.jhep.2020.04.044)"},{"key":"bib53","series-title":"Phytomedicine","article-title":"Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice","volume":"101","author":"Huang S","year":"2022","unstructured":"Huang S\n, \nWang Y\n, \nXie S\n, et al.\n Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice. Phytomedicine 2022 101 154117. (https:\/\/doi.org\/10.1016\/j.phymed.2022.154117)"},{"key":"bib54","series-title":"Pharmacol Res","article-title":"Hepatic stellate cells role in the course of metabolic disorders development \u2013 a molecular overview","volume":"170","author":"Bourebaba N","year":"2021","unstructured":"Bourebaba N\n & \nMarycz K\n\n. Hepatic stellate cells role in the course of metabolic disorders development \u2013 a molecular overview. Pharmacol Res 2021 170 105739. (https:\/\/doi.org\/10.1016\/j.phrs.2021.105739)"},{"key":"bib55","series-title":"Biomed Pharmacother","article-title":"Current status of GABA receptor subtypes in analgesia","volume":"168","author":"Qian X","year":"2023","unstructured":"Qian X\n, \nZhao X\n, \nYu L\n, et al.\n Current status of GABA receptor subtypes in analgesia. Biomed Pharmacother 2023 168 115800. (https:\/\/doi.org\/10.1016\/j.biopha.2023.115800)"},{"key":"bib56","series-title":"Diabetes Obes Metab","first-page":"5085","article-title":"GABA ameliorates diet-induced hepatic steatosis and insulin resistance by inhibiting macrophage activation","volume":"27","author":"Cui Q","year":"2025","unstructured":"Cui Q\n, \nYang Q\n, \nWang Z\n, et al.\n GABA ameliorates diet-induced hepatic steatosis and insulin resistance by inhibiting macrophage activation. Diabetes Obes Metab 2025 27 5085\u20135098. (https:\/\/doi.org\/10.1111\/dom.16556)"},{"key":"bib57","series-title":"Anim Nutr","first-page":"280","article-title":"Gama-aminobutyric acid (GABA) alleviates hepatic inflammation via GABA receptors\/TLR4\/NF-\u03baB pathways in growing-finishing pigs generated by super-multiparous sows","volume":"9","author":"Zhang S","year":"2022","unstructured":"Zhang S\n, \nZhao J\n, \nHu J\n, et al.\n Gama-aminobutyric acid (GABA) alleviates hepatic inflammation via GABA receptors\/TLR4\/NF-\u03baB pathways in growing-finishing pigs generated by super-multiparous sows. Anim Nutr 2022 9 280\u2013290. (https:\/\/doi.org\/10.1016\/j.aninu.2022.02.001)"},{"key":"bib58","series-title":"Ecotoxicol Environ Saf","article-title":"Effects of ammonia toxicity on the histopathology, detoxification, oxidative stress, and immune response of the cuttlefish Sepia pharaonis and the mitigation of \u03b3-aminobutyric acid","volume":"232","author":"Liang Y","year":"2022","unstructured":"Liang Y\n, \nWu Y\n, \nLi J\n, et al.\n Effects of ammonia toxicity on the histopathology, detoxification, oxidative stress, and immune response of the cuttlefish Sepia pharaonis and the mitigation of \u03b3-aminobutyric acid. Ecotoxicol Environ Saf 2022 232 113256. (https:\/\/doi.org\/10.1016\/j.ecoenv.2022.113256)"},{"key":"bib59","series-title":"Cell Rep","article-title":"A critical role of hepatic GABA in the metabolic dysfunction and hyperphagia of obesity","volume":"35","author":"Geisler CE","year":"2021","unstructured":"Geisler CE\n, \nGhimire S\n, \nBruggink SM\n, et al.\n A critical role of hepatic GABA in the metabolic dysfunction and hyperphagia of obesity. Cell Rep 2021 35 109301. (https:\/\/doi.org\/10.1016\/j.celrep.2021.109301)"},{"key":"bib60","series-title":"Elife","article-title":"Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia\/reperfusion injury through inhibiting ferroptosis","volume":"12","author":"Wang F","year":"2024","unstructured":"Wang F\n, \nLiu X\n, \nHuang F\n, et al.\n Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia\/reperfusion injury through inhibiting ferroptosis. Elife 2024 12 RP89045. (https:\/\/doi.org\/10.7554\/eLife.89045)"},{"key":"bib61","series-title":"Dev Cell","first-page":"1053","article-title":"The de novo synthesis of GABA and its gene regulatory function control hepatocellular carcinoma metastasis","volume":"60","author":"Li L","year":"2025","unstructured":"Li L\n, \nKang Y\n, \nCheng R\n, et al.\n The de novo synthesis of GABA and its gene regulatory function control hepatocellular carcinoma metastasis. Dev Cell 2025 60 1053\u20131069.e6. (https:\/\/doi.org\/10.1016\/j.devcel.2024.12.007)"},{"key":"bib62","series-title":"Nat Methods","first-page":"635","article-title":"Ultra-high-throughput single-cell RNA sequencing and perturbation screening with combinatorial fluidic indexing","volume":"18","author":"Datlinger P","year":"2021","unstructured":"Datlinger P\n, \nRendeiro AF\n, \nBoenke T\n, et al.\n Ultra-high-throughput single-cell RNA sequencing and perturbation screening with combinatorial fluidic indexing. Nat Methods 2021 18 635\u2013642. (https:\/\/doi.org\/10.1038\/s41592-021-01153-z)"},{"key":"bib63","series-title":"Cells","first-page":"1070","article-title":"High-throughput transcriptomics of Celf1 conditional knockout lens identifies downstream networks linked to cataract pathology","volume":"12","author":"Siddam AD","year":"2023","unstructured":"Siddam AD\n, \nDuot M\n, \nCoomson SY\n, et al.\n High-throughput transcriptomics of Celf1 conditional knockout lens identifies downstream networks linked to cataract pathology. Cells 2023 12 1070. (https:\/\/doi.org\/10.3390\/cells12071070)"},{"key":"bib64","series-title":"Front Genet","article-title":"RNA sequencing and integrative analysis reveal pathways and hub genes associated with TGF\u03b21 stimulation on prostatic stromal cells","volume":"13","author":"Xiang P","year":"2022","unstructured":"Xiang P\n, \nDu Z\n, \nWang M\n, et al.\n RNA sequencing and integrative analysis reveal pathways and hub genes associated with TGF\u03b21 stimulation on prostatic stromal cells. Front Genet 2022 13 919103. (https:\/\/doi.org\/10.3389\/fgene.2022.919103)"},{"key":"bib65","series-title":"Sci Rep","article-title":"PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity","volume":"12","author":"Furuya H","year":"2022","unstructured":"Furuya H\n, \nSasaki Y\n, \nChen R\n, et al.\n PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity. Sci Rep 2022 12 12186. (https:\/\/doi.org\/10.1038\/s41598-022-16518-3)"},{"key":"bib66","series-title":"Int J Mol Sci","first-page":"5933","article-title":"Eupatilin ameliorates hepatic fibrosis and hepatic stellate cell activation by suppressing \u03b2-catenin\/PAI-1 pathway","volume":"24","author":"Hu J","year":"2023","unstructured":"Hu J\n, \nLiu Y\n, \nPan Z\n, et al.\n Eupatilin ameliorates hepatic fibrosis and hepatic stellate cell activation by suppressing \u03b2-catenin\/PAI-1 pathway. Int J Mol Sci 2023 24 5933. (https:\/\/doi.org\/10.3390\/ijms24065933)"},{"key":"bib67","series-title":"Semin Thromb Hemost","first-page":"305","article-title":"Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1)","volume":"49","author":"Morrow GB","year":"2023","unstructured":"Morrow GB\n & \nMutch NJ\n\n. Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1). Semin Thromb Hemost 2023 49 305\u2013313. (https:\/\/doi.org\/10.1055\/s-0042-1758791)"},{"key":"bib68","series-title":"Biochem Biophys Res Commun","first-page":"536","article-title":"Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-beta signaling pathway","volume":"393","author":"Min AK","year":"2010","unstructured":"Min AK\n, \nKim MK\n, \nSeo HY\n, et al.\n Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-beta signaling pathway. Biochem Biophys Res Commun 2010 393 536\u2013541. (https:\/\/doi.org\/10.1016\/j.bbrc.2010.02.050)"},{"key":"bib69","series-title":"Free Radic Biol Med","first-page":"620","article-title":"Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis","volume":"193","author":"Cho SS","year":"2022","unstructured":"Cho SS\n, \nYang JH\n, \nLee JH\n, et al.\n Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis. Free Radic Biol Med 2022 193 620\u2013637. (https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.11.011)"},{"key":"bib70","series-title":"Metabolism","article-title":"S100a16 deficiency prevents hepatic stellate cells activation and liver fibrosis via inhibiting CXCR4 expression","volume":"135","author":"Zhang WS","year":"2022","unstructured":"Zhang WS\n, \nZhang R\n, \nGe Y\n, et al.\n S100a16 deficiency prevents hepatic stellate cells activation and liver fibrosis via inhibiting CXCR4 expression. Metabolism 2022 135 155271. (https:\/\/doi.org\/10.1016\/j.metabol.2022.155271)"},{"key":"bib71","series-title":"Cell Rep","article-title":"PAI-1 uncouples integrin-\u03b21 from restrain by membrane-bound \u03b2-catenin to promote collagen fibril remodeling in obesity-related neoplasms","volume":"43","author":"Lin LL","year":"2024","unstructured":"Lin LL\n, \nNayak B\n, \nOsmulski PA\n, et al.\n PAI-1 uncouples integrin-\u03b21 from restrain by membrane-bound \u03b2-catenin to promote collagen fibril remodeling in obesity-related neoplasms. Cell Rep 2024 43 114527. (https:\/\/doi.org\/10.1016\/j.celrep.2024.114527)"},{"key":"bib72","series-title":"Front Immunol","article-title":"Herbal HuoXueTongFu formula with anti-inflammatory and fibrinolytic activity regulation for the prevention of postoperative peritoneal adhesions","volume":"15","author":"Yang L","year":"2024","unstructured":"Yang L\n, \nWang Y\n, \nLi Z\n, et al.\n Herbal HuoXueTongFu formula with anti-inflammatory and fibrinolytic activity regulation for the prevention of postoperative peritoneal adhesions. Front Immunol 2024 15 1510766. (https:\/\/doi.org\/10.3389\/fimmu.2024.1510766)"},{"key":"bib73","series-title":"Blood","first-page":"2464","article-title":"Targeting FXR in hepatocytes: a promising approach to enhance fibrinolysis and reduce deep vein thrombosis risk","volume":"146","author":"Li B","year":"2025","unstructured":"Li B\n, \nFan H\n, \nWu H\n, et al.\n Targeting FXR in hepatocytes: a promising approach to enhance fibrinolysis and reduce deep vein thrombosis risk. Blood 2025 146 2464\u20132478. (https:\/\/doi.org\/10.1182\/blood.2024027772)"}],"container-title":["Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/269\/3\/JOE-25-0300.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/269\/3\/JOE-25-0300.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/269\/3\/JOE-25-0300.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:40:31Z","timestamp":1781264431000},"score":1,"resource":{"primary":{"URL":"https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/269\/3\/JOE-25-0300.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":146,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/joe-25-0300","relation":{},"ISSN":["0022-0795","1479-6805"],"issn-type":[{"value":"0022-0795","type":"print"},{"value":"1479-6805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}